MAPK8IP2 is a potential prognostic biomarker and promote tumor progression in prostate cancer. Zeng Z, He W, Jiang Y, Jiang H, et al. BMC Cancer 2022;22:1162.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Zeng Z, He W, Jiang Y, Jiang H, et al. MAPK8IP2 is a potential prognostic biomarker and promote tumor progression in prostate cancer. BMC Cancer 2022;22:1162.
PMID: 36357836